Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The goal is to reach a dose thats effective and tolerable for you
Unlike pharmaceutical sleep aids that cause next-day drowsiness, cognitive impairment, tolerance, and dependency, DSIP enhances sleep quality without sedative side effects, maintains normal sleep architecture, causes no morning grogginess, develops no tolerance requiring dose escalation, and demonstrates no withdrawal symptoms or addiction potential
Erica Oberg's telehealth GLP-1 Treatments, Semaglutide or Tirzepatide medical weight loss program in Spring Valley, CA starts to make a lot of sense
Phase 2 Efficacy and Safety: The Core Dataset The key Phase 2 trial (NCT04881706) randomized 338 adults with obesity or overweight plus at least one comorbidity to placebo or one of six retatrutide dose levels (1 mg, 4 mg escalated from different starting doses, 8 mg, or 12 mg) for 48 weeks [1]
